Clinical trials recruiting in Overpelt, Belgium

Phase breakdown

Conditions recruiting in Overpelt, Belgium

Recruiting trials in Overpelt, Belgium

• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
  NCT06846281 · Phase: Phase 3 · Ages: 40 Years to 70 Years · Sex: All (male and female)
• LimPrOn: Limburg Pre-eclampsia Investigation
  NCT03509272 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: Female
• Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
  NCT07325292 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Overpelt, Belgium?

3 recruiting trials have at least one study site in Overpelt, Belgium.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.